In conclusion, we provided the first experimental evidence of the transmission of an AD-like phenotype in a non-human primate that includes Aβ and tau pathologies as well as cognitive impairments and cerebral atrophy. The gene discussed is MAPT; the disease is Cerebral atrophy.